Dr Karen Anthony is a leading researcher on RNA processing and RNA-based therapeutics. Karen has worked on a number of drug and disease targets including tau and TDP-43 for Alzheimer's and motor neurone disease.
Working with Professor Francesco Muntoni at University College London (UCL)...
Click to Expand >>
Dr Karen Anthony is a leading researcher on RNA processing and RNA-based therapeutics. Karen has worked on a number of drug and disease targets including tau and TDP-43 for Alzheimer's and motor neurone disease.
Working with Professor Francesco Muntoni at University College London (UCL) her pioneering and ongoing work has focused on neuromuscular disorders and the pre-clinical and clinical development of exon skipping as a therapeutic approach for Duchenne muscular dystrophy (DMD). Karen has developed, optimised and validated standardised protocols to accurately quantify dystrophin mRNA and protein in clinical trials and has helped international pharmaceutical companies with methodology for clinical trial biochemical outcome measures.
Karen is also motivated to promote wider participation in higher education and is involved with several outreach and science communication programmes. Karen writes about academic life on her blog, Weekademia.
Click to Shrink <<